Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Fracture risk in patients rece...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Fracture risk in patients receiving concomitant bisphosphonate and proton pump inhibitors or bisphosphonates alone: The UK general practice research database
Bibliographic Details
Main Authors:
de Vries, F
,
Cooper, A
,
Logan, R
,
Cockle, S
,
Cooper, C
,
van Staa, T
Format:
Journal article
Published:
2008
Holdings
Description
Similar Items
Staff View
Similar Items
Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates.
by: de Vries, F, et al.
Published: (2009)
Is persistence to bisphosphonate therapy related only to dosing regimen?
by: van Staa, T, et al.
Published: (2006)
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
by: van Staa, T, et al.
Published: (2007)
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
by: van Staa, T, et al.
Published: (2007)
The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
by: Zaoqian Zheng, et al.
Published: (2020-09-01)